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Research
AbstrACt
Objective To investigate the effects of lifestyle and 
vascular-related risk factors for Alzheimer’s disease (AD) 
on in vivo MRI-based brain atrophy in asymptomatic young 
to middle-aged adults.
Design Cross-sectional, observational.
setting Broader New York City area. Two research centres 
affiliated with the Alzheimer’s disease Core Center at New 
York University School of Medicine.
Participants We studied 116 cognitively normal 
healthy research participants aged 30–60 years, 
who completed a three-dimensional T1-weighted 
volumetric MRI and had lifestyle (diet, physical activity 
and intellectual enrichment), vascular risk (overweight, 
hypertension, insulin resistance, elevated cholesterol 
and homocysteine) and cognition (memory, executive 
function, language) data. Estimates of cortical 
thickness for entorhinal (EC), posterior cingulate, 
orbitofrontal, inferior and middle temporal cortex were 
obtained by use of automated segmentation tools. We 
applied confirmatory factor analysis and structural 
equation modelling to evaluate the associations 
between lifestyle, vascular risk, brain and cognition.
results Adherence to a Mediterranean-style diet (MeDi) 
and insulin sensitivity were both positively associated 
with MRI-based cortical thickness (diet: βs≥0.26, insulin 
sensitivity βs≥0.58, P≤0.008). After accounting for vascular 
risk, EC in turn explained variance in memory (P≤0.001). 
None of the other lifestyle and vascular risk variables 
were associated with brain thickness. In addition, the path 
associations between intellectual enrichment and better 
cognition were significant (βs≥0.25 P≤0.001), as were 
those between overweight and lower cognition (βs≥-0.22, 
P≤0.01).
Conclusions In cognitively normal middle-aged adults, 
MeDi and insulin sensitivity explained cortical thickness 
in key brain regions for AD, and EC thickness predicted 
memory performance in turn. Intellectual activity and 
overweight were associated with cognitive performance 
through different pathways. Our findings support 
further investigation of lifestyle and vascular risk factor 
modification against brain ageing and AD. More studies 
with larger samples are needed to replicate these research 
findings in more diverse, community-based settings.
IntrODuCtIOn 
Alzheimer’s disease (AD) is the most common 
form of dementia, affecting nearly 34 million 
people worldwide.1 Unless effective strategies 
for prevention are found, the prevalence of 
AD is expected to triple by 2050.
strengths and limitations of this study
 ► One of the key strengths of this study is the avail-
ability of a well-characterised population of asymp-
tomatic middle-aged healthy adults with multiple 
lifestyle and vascular risk measures, as well as 
neuroimaging.
 ► Our statistical approach using confirmatory factor 
analysis and structural equation modelling allowed 
us to simultaneously discern the independent and 
inter-related effects of several lifestyle variables and 
vascular risk factors on brain atrophy and cognition.
 ► A limitation of the study was its cross-sectional na-
ture. Longitudinal studies with larger samples are 
necessary to test for temporal and causal inter-rela-
tionship between modifiable risk factors and future 
Alzheimer’s disease (AD).
 ► We caution that participants were carefully screened 
research participants, which limits our ability to gen-
eralise results to the entire population. More studies 
are needed to replicate these research findings in 
community-based settings.
 ► MRI measures are largely seen as biomarkers of 
neurodegeneration associated with AD. However, 
biomarkers specific to AD pathology (amyloid and 
tau pathology) are warranted to determine whether 
the associations between lifestyle and vascular risk 
are indeed related to ongoing AD.
2 Mosconi L, et al. BMJ Open 2018;8:e019362. doi:10.1136/bmjopen-2017-019362
Open Access 
Given the current lack of disease-modifying treatment,2 
and increasing awareness that AD pathology develops 
over many years prior to clinical symptoms,3 the potential 
for prevention is crucial to reduce AD risk and/or delay 
the onset of cognitive decline.
There is substantial epidemiological evidence linking 
modifiable risk factors, such as midlife hypertension, 
obesity, diabetes, poor diet, physical and intellectual inac-
tivity, with increased risk of late-onset AD. Recent popula-
tion-attributable models estimated that one in every three 
cases of AD may be accounted for by these lifestyle and 
vascular-related risk factors.1 4 As a result, trends in AD 
risk reduction research have focused on lifestyle interven-
tions as well as vascular risk reduction.2 3 5
While the importance of lifestyle and vascular risk 
management in health is well understood, their specific 
effects on AD pathophysiology, and thus their effective-
ness for AD prevention are less clear.6
Conflicting results in the literature may be due to the 
use of different patient populations, different lifestyle 
measures, different statistical constructs and an overall 
lack of AD biomarkers. Moreover, though a combined 
reduction in risk factors is projected to have a greater 
impact than any one factor alone,4 most studies have 
examined one or few variables at a time.7 Further, 
although there is consensus that preventative interven-
tions have the highest chances of success when imple-
mented in midlife,2 the majority of studies focused on the 
elderly, including those already experiencing cognitive 
impairment.8–14
Neuropathologically, AD is characterised by the pres-
ence of amyloid-beta (Aβ) plaques, neurofibrillary tangles 
and neuronal loss in selectively vulnerable brain regions.6 
Neuronal loss in AD originates in the medial temporal 
lobes during the normal stages of cognition and spreads 
to cortical regions with disease progression.15 MRI has 
long been used to visualise neurodegeneration in vivo. 
Several MRI studies have shown that brain cortical thin-
ning (ie, atrophy) in AD-vulnerable regions begins many 
years prior to dementia onset, making this biomarker an 
ideal candidate to monitor the effectiveness of preventa-
tive interventions.16
This study examines the simultaneous effects of 
multiple modifiable lifestyle and vascular risk factors on 
MRI-based cortical atrophy in a cohort of middle-aged 
healthy adults at risk for AD.
MethODs
Participants
Participants were enrolled in observational brain imaging 
studies of clinically and cognitively normal middle-aged 
adults conducted at two research centres affiliated with 
the Alzheimer’s disease Coordinating Center of New 
York University (NYU) School of Medicine between 
2010 and 2016. Details about the studies have previously 
been published.17–21 All participants provided informed 
consent to participate in this study.
Briefly, participants were derived from multiple 
community sources, including individuals interested in 
research participation, family members and caregivers 
of impaired patients. Subjects were 30–60 years old, with 
≥12-year education, Clinical Dementia Rating=0, Global 
Deterioration Scale<2, Hamilton depression scale <16 
and normal cognitive test performance for age and educa-
tion.22 Because our goal was to examine the influence of 
lifestyle and vascular risk factors in healthy middle-aged 
participants without overt cardiovascular and/or cerebro-
vascular disease, we excluded individuals with Modified 
Hachinski Ischaemia scale score >4. Those with medical 
conditions or history of conditions that may affect brain 
structure or function (eg, stroke, poorly controlled 
diabetes, head trauma, any neurodegenerative diseases, 
depression, hydrocephalus, intracranial mass and infarcts 
on MRI) and those taking steroids or psychoactive medi-
cations were excluded. Only participants with clinical, 
laboratory, neuropsychological, volumetric MRI examina-
tions and lifestyle questionnaires within 6 months of each 
other were included.
A family history of AD that included at least one first-de-
gree relative whose AD onset was after age 60 was elic-
ited using standardised questionnaires.17 Apolipoprotein 
Table 1 Participants’ demographic and clinical 
characteristics
n 116
Age, years 50 (6), range 30–60
Sex, % female 62
Education, years 16 (2), range 12–22
Family history of LOAD, % 
positive
38
APOE ε4 carriers, % positive 40
Ethnicity, % white 68




  BMI (kg/cm2) 25 (4), range 18–37
  Hypertension, % positive 14
  QUICKI score (unitless) 0.32 (0.03)
  Plasma cholesterol/HDL ratio 
(unitless)
3.3 (0.8)
  Plasma homocysteine (µmol/L) 7.9 (6.2)
Lifestyle measures
  Mediterranean diet (unitless) 4.3 (1.9), range 1–8
  Physical activity (metabolic 
equivalent/hour)
9.8 (6.3), range 1–37
  Intellectual activity (unitless) 3.7 (0.7), range 1.8–4.9*
Values are mean (SD) unless otherwise specified.
*Data were not available for 20 out of 116 patients.
APOE, apolipoprotein E; BMI, body mass index; HDL, high-density 
lipoprotein; LOAD, late-onset Alzheimer's disease; QUICKI, 
Quantitative Insulin Sensitivity Check Index.
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E (APOE) genotypes were determined using standard 
quantitative PCR procedures.17
Cognitive measures
The neuropsychological battery of tests was previously 
described.22 Briefly, three cognitive domains were assessed 
from the following tests: memory (immediate and delayed 
recall of a paragraph and immediate and delayed recall 
of paired associates), executive function (Wechsler Adult 
Intelligence Scale (WAIS) digit symbol substitution) and 
language (WAIS vocabulary).
We modelled memory as a latent factor composed 
of standardised versions of immediate and delayed 
recall scores using confirmatory factor analysis (CFA) 
(alpha=0.84). The three cognitive domains were exam-
ined as outcome variables (see Statistical analysis).
Vascular risk measures
Vascular risk factors included in the model were: (1) 
overweight, measured using the body mass index (BMI, 
kg/m2); (2) presence of hypertension, conservatively 
determined based on either current antihypertensive 
treatment or blood pressure assessments; (3) elevated 
plasma cholesterol and/or elevated plasma homocysteine, 
as obtained after overnight fasting using standard labora-
tory procedures and (4) insulin sensitivity, measured with 
the Quantitative Insulin Sensitivity Check Index,23 where 
lower scores reflect greater insulin resistance and higher 
scores reflect insulin sensitivity.
Lifestyle measures
Diet
Dietary data regarding average food consumption over 
the prior year were obtained using the Block or Harvard 
food frequency questionnaire, as previously described.19 
Briefly, food items were categorised into food groups 
based on similarities in food and nutrient composi-
tion, and intake of each food group was calculated by 
summing the intakes of food group items. Mediterra-
nean diet (MeDi) scores were generated as the sum of 
caloric intake-adjusted daily gram intake dichotomised 
Figure 1 Assessing the impact of lifestyle and vascular risk factors on brain ageing and cognition. Results of the following 
SEMs. (A) Relationships between lifestyle, vascular risk and brain, excluding cognition from the model. (B) Relationships 
between lifestyle, brain and cognition, excluding vascular risk from the model. (C) Relationships between vascular risk, brain 
and cognition, excluding lifestyle from the model. Red lines indicate the significant effects observed in our data. Purple lines 
indicate significant alternate paths. Blue lines indicate significant correlational effects. Grey lines indicate associations which 
were tested but found to be non-significant. Numbers beside the lines are standardised beta coefficients and corresponding P 
values: *P<0.01; **P<0.001. Not shown here, all brain ROI variables were correlated with one another (see online supplementary 
etable 1). Direct associations between lifestyle and vascular risk factors are found in online supplementary etable 2. Variables 
in squares are measured variables (eg, one variable represents this construct). Variables in circles are latent variables (multiple 
variables were averaged using a CFA to represent that construct). Straight lines indicate causal relationships, curved lines 
indicate correlational relationships. Age was entered as a covariate. Brain biomarkers were examined with and without adjusting 
for total intracranial volume. CFA, confirmatory factor analysis; ROI, region of interest; SEMs, structural equation models.
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relative to the sex-specific median for each beneficial 
(fruits, vegetables, legumes, cereals and fish; monounsat-
urated to saturated fat ratio; mild to moderate alcohol 
consumption) versus detrimental (meat and dairy prod-
ucts) component.19 24 Greater score indicate greater 
MeDi adherence.
Physical activity
The Baecke and Minnesota leisure time physical activity 
questionnaires were used to estimate the current level 
of physical activity.25 26 For each activity, information 
was collected on the frequency and duration of engage-
ment over the past year. Frequency and duration 
data were multiplied with an activity-specific intensity 
code indicating calorie expenditure. We standardised 
and summed the activity-dependent scores from each 
test to obtain the overall annual intensity of physical 
activity per person, which was converted to metabolic 
equivalents.
Intellectual enrichment
Intellectual activity and years of education were used as 
measures of intellectual enrichment as described below. 
Intellectual activity throughout life was assessed using a 
validated 25-item interview in which participants were 
asked to report how often they engaged in common 
cognitively demanding activities that depend mini-
mally on socioeconomic status, such as reading books 
or newspapers, writing letters or e-mails, going to the 
library and playing games at different age epochs.9 27 
Previous studies described this instrument in detail and 
reported high internal consistency and positive associa-
tions of intellectual activity with educational and cogni-
tive performance.27
MRI acquisition and processing
All subjects received three-dimensional volumetric 
T1-weighted MRI on a 3T scanner according to published 
protocols.17–21 MRIs were acquired and preprocessed as 
described.19 28 Volumetric segmentation, cortical surface 
reconstruction and parcellation were performed using 
the FreeSurfer V.5.3 software package.29 30 Cortical thick-
ness measures were obtained for a subset of a priori-de-
fined regions of interest (ROIs) known to show atrophic 
changes early in AD and in association with lifestyle7: 
entorhinal cortex (EC), posterior cingulate cortex (PCC), 
orbitofrontal cortex, inferior and middle temporal gyrus. 
FreeSurfer was also used to derive total intracranial 
volumes (TIV) to adjust for individual variability.
A latent factor of brain structure was generated by 
combining the ROI thickness measures using CFA to repre-
sent that construct. Instead of predicting each of these ROIs 
individually, the latent factor predicts their shared variance 
(ie, intercorrelation). EC was set as the marker variable. All 
ROIs were strongly correlated with each other (alpha >0.78, 
see online supplementary etable 1).
statistical analysis
We constructed structural equation models (SEMs) 
(MPlus V.731) to evaluate interdependent relationships 
among the four sets of variables: lifestyle (diet, phys-
ical activity and intellectual enrichment), vascular-re-
lated risk (overweight, hypertension, insulin resistance, 
elevated plasma cholesterol and homocysteine levels), 
MRI biomarkers (latent variable of brain structure) and 
cognitive measures (latent variable of memory, executive 
function and language).
The three cognitive domains were modelled as a func-
tion of lifestyle variables, vascular variables and MRI 
biomarkers (see online supplementary efigure 1). Life-
style and vascular variables were specified as exogenous 
variables. Brain structure formed an intermediate layer 
of endogenous variables, and the cognitive domains were 
the final downstream endogenous variables. As such, 
exogenous variables (lifestyle and vascular risk measures) 
predicted brain variables, and brain variables in turn 
predicted cognition. We regressed brain structure on 
the lifestyle and vascular variables. We then regressed 
Table 2 Results of structural equation modelling for model 
1: lifestyle, vascular risk and brain
βs SE P value
Associations between lifestyle and brain MRI biomarkers
  Diet → Brain 0.260 0.099 0.009
  Diet → Brain 0.204 0.086 0.018
  Physical activity → Brain −0.130 0.108
  Physical activity → Brain −0.058 0.047
  Intellectual enrichment → 
Brain
−0.192 0.098
  Intellectual enrichment → 
Brain
−0.190 0.102
Associations between vascular risk and brain MRI 
biomarkers
  Overweight → Brain −0.067 0.101
  Overweight → Brain −0.116 0.173
  Insulin sensitivity → Brain 0.559 0.081 <0.001
  Insulin sensitivity → Brain 0.029 0.006 <0.001
  Plasma cholesterol/HDL → 
Brain
−0.038 0.101
  Plasma cholesterol/HDL → 
Brain
−0.010 0.037
  Plasma homocysteine → 
Brain
0.177 0.315
  Plasma homocysteine → 
Brain
0.175 0.372
  Hypertension → Brain 0.076 0.106
  Hypertension → Brain 0.032 0.042
The table consists of standardised betas (βs), their SEs and P 
values of the estimates from the full model with age entered as a 
covariate. The βs can be interpreted as partial correlations. Only 
significant P values (two tailed) are reported. Paths in italics are 
adjusted for sex and APOE status as covariates.
APOE, apolipoprotein E; HDL, high-density lipoprotein.
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cognitive domains on all other variables in the model. 
Additionally, ran a separate model in which we replace 
the latent variable of brain structure with the two limbic 
regions (ie, EC and PCC) based on evidence of their 
earlier predictive capacity.
Since variables in the two exogenous domains, life-
style and vascular risk, were only marginally related to 
each other (see Results), the model was further broken 
down into the following three submodels: (1) we first 
modelled the relationships between lifestyle, vascular risk 
and brain, excluding cognition from the model; (2) we 
modelled the relationships between lifestyle, brain and 
cognition, excluding vascular risk and (3) we modelled 
the relationships between vascular risk, brain and cogni-
tion, excluding lifestyle from the model.
All models were adjusted for the intercorrelations 
between lifestyle variables, vascular-risk variables, 
brain structure and cognitive measures as appro-
priate. Age, gender and APOE status were examined 
as covariates. Brain measures were evaluated with and 
without adjustment for TIV.
For each analysis, we first fit the full models, esti-
mating all paths and then assessed the reduced models 
suggested by the primary analysis (eg, with non-signif-
icant paths removed). We used χ2 statistic, comparative 
fit index (CFI) and root mean square error of approxi-
mation (RMSEA) goodness of fit tests to indicate model 
fits for the full models. Each of these measures incorpo-
rates unique criteria to assess fit so a summary of all three 
measures provides a more comprehensive estimate. After 
the path coefficients were derived, the paths were thresh-
olded to achieve a second, more parsimonious model, by 
eliminating paths with P values >0.05. Path elimination 
was monitored via the χ2, CFI and RMSEA. Good model 
fit can be reflected by a χ2 to df ratio <2.0,32 a CFI>0.8533 
and an RMSEA<0.06.34 The CFI and RMSEA are among 
the measures least affected by sample size and perform 
very well at all sample sizes.32 As such, CFI and RMSEA 
were our primary reporting criteria for the reduced 
models.
Some of the reduced models were saturated (eg, these 
models accounted for all possible relationships that 
could exist among variables in our dataset), making 
overall model fit statistics not applicable. In this case, we 
focused on specific paths and path significance rather 
than omnibus measures model fits. The standardised 
beta coefficients (βs) can be interpreted as partial correla-
tions. Given that all of the paths are standardised, one 
can judge meaningfulness by their raw and comparative 
path weights. All analyses used maximum likelihood esti-
mation in the MPlus package.31
resuLts
Participants
A total of 116 participants were included in the analysis 
(table 1). Participants were on average 50 years old (range 
25–60), 62% women, with education ≥12 years. Of these, 
38% had a family history of AD, and 40% had at least one 
copy of the APOE4 allele (APOE4 carriers).
structural equation modelling
In the full model, age was associated with risk of hyper-
tension (βs=0.18, P=0.049) and, although it tended to be 
negatively related to brain structure (βs=−0.10 to −0.19, 
ns), it was not significantly associated with the lifestyle or 
cognitive variables.
Men, as expected, showed higher vascular risk than 
women, as reflected in a higher frequency of hypertension, 
elevated cholesterol and homocysteine levels (P<0.04). 
Women showed better executive function performance 
than men (P<0.001). Sex was not significantly or marginally 
related to lifestyle variables or brain structure.
APOE status was not associated with lifestyle or cogni-
tive variables but was associated with plasma cholesterol 
(P=0.033) and marginally associated with brain structure 
(P=0.07). These effects were driven by APOE4 carriers 
exhibiting higher cholesterol levels and reduced cortical 
thickness than non-carriers.
Given these relationships, all subsequent analyses were 
performed with and without adjusting for age, sex and 
APOE, as appropriate.
Among lifestyle variables, with and without controlling 
for the above confounds, participants with higher intel-
lectual enrichment showed higher MeDi adherence 
(βs≥0.27, P≤0.028). Otherwise, lifestyle variables were not 
significantly related to one another.
Among vascular variables, BMI was negatively associ-
ated with insulin sensitivity (βs=−0.27, P<0.01) and posi-
tively associated with cholesterol levels and hypertension 
(βs=0.32 and βs=0.29, P<0.001). Cholesterol levels and 
hypertension were associated with each other (βs=0.24, 
P<0.05).
Vascular and lifestyle variables were not associated with 
each other, except for higher intellectual enrichment 
correlating with lower risk of hypertension (βs=−0.22, 
P<0.05), and insulin sensitivity was marginally, though not 
significantly, associated with diet (βs=0.12, P=0.18). The 
model was therefore broken down in the following three 
submodels:
Lifestyle, vascular risk and MrI-based biomarkers
Figure 1 represents the path diagrams from model 1, 
which exhibited adequate fit, χ2(41)≥95.37, RMSEA<0.05, 
CFI≥0.85, P<0.001. Controlling for age, diet and insulin 
sensitivity were the only factors positively associated 
with brain structure (βs≥0.26 and βs≥0.58, respectively, 
P≤0.008, table 2). The reduced model fit the data well 
(RMSEA <0.01, CFI≥0.90) reflecting the fact that diet and 
insulin sensitivity both significantly and independently 
predicted brain structure (diet: βs=0.20, P=0.017 and 
insulin sensitivity: βs=0.57, P<0.001), consistent with the 
pattern of significant and non-significant paths obtained 
in full model 1. Including sex and APOE status as covari-
ates did not significantly influence these relationships 
(table 2).
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Restricting analysis to limbic structures fit the data well 
(RMSEA <0.05, CFI=1.0), confirming that insulin sensi-
tivity was positively associated with both EC and PCC 
(βs=0.42 and βs=0.38, P<0.001), and diet was associated 
with PCC (βs=0.23, P=0.004) and marginally with EC 
(βs=0.13, P=0.12) (figure 2).
Lifestyle, MrI-based biomarkers and cognition
Model 2 exhibited adequate fit, χ2(64)≥108.51, RMSEA 
<0.05, CFI≥0.90, P<0.001. The reduced models were 
completely saturated (eg, all possible relationships that 
could exist among variables in the dataset were accounted 
for). As such, we focused on specific paths and path signif-
icance rather than omnibus measures of model fit.
As in model 1, with and without adjusting for age and 
TIV, diet was the only lifestyle factor positively associated 
with brain structure (βs≥0.27, P≤0.02, table 3 and figure 1). 
Diet and physical activity were not associated with cognitive 
function, whereas intellectual enrichment was positively 
associated with cognition (P<0.05, table 3). Specifically, 
intellectual activity was positively associated with memory 
and executive function (βs=0.28 and βs=0.39, respectively, 
P<0.02), and marginally with language (βs=0.25, P=0.08). 
Education positively predicted memory, executive func-
tion and language (βs=0.21–0.33, P≤0.038).
Brain structure was not significantly associated with 
cognition. However, when analyses were restricted to 
limbic structures, diet showed positive associations with 
PCC (βs=0.27, P=0.006) and EC (βs=0.17, P=0.08), which 
in turn positively, though marginally, predicted memory 
(βs=0.19, P=0.078) (figure 2).
Including sex and APOE status as covariates did not 
influence the other relationships of interest in any of the 
models (table 3).
Vascular risk, MrI-based biomarkers and cognition
Model three exhibited adequate fit, χ2(78)≥151.54, 
RMSEA <0.05, CFI≥0.89, P<0.001. The reduced 
models were completely saturated and overall model 
fit statistics were not applicable. Below, we focus on 
path significance rather than omnibus measures of 
model fit.
As in model 1, insulin sensitivity was the only vascular 
factor associated with brain structure (βs=0.58, P<0.01, 
table 4 and figure 1). Brain structure was not significantly 
associated with cognition. However, when analysis was 
restricted to limbic structures, insulin sensitivity showed 
positive associations with EC (βs=0.30, P<0.001) and EC 
in turn positively predicted memory (βs=0.39, P<0.001) 
(figure 2). Additionally, BMI was negatively associated 
with memory and executive function (βs=−0.22 and 
βs=−0.27, P≤0.021, figure 2).
Including sex and APOE status as covariates did not 
significantly influence the other relationships of interest 
(table 4).
Figure 2 Assessing the impact of lifestyle and vascular risk factors on limbic brain structures and cognition. Results of the 
following SEMs. (A) Relationships between lifestyle, vascular risk and limbic brain, excluding cognition from the model. (B) 
Relationships between lifestyle, limbic brain and cognition, excluding vascular risk from the model. (C) Relationships between 
vascular risk, limbic brain and cognition, excluding lifestyle from the model. See legend to figure 1. Age was entered as a 
covariate. Brain measures were examined with and without adjusting for total intracranial volume. *P<0.01; **P<0.001. EC, 
entorhinal cortex; PCC, posterior cingulate cortex; SEMs, structural equation models.
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Table 3 Results of structural equation modelling for model 
2: lifestyle, brain and cognition
βs SE P value
Associations between lifestyle and brain MRI biomarkers
  Diet → Brain 0.253 0.098 0.010
  Diet → Brain 0.253 0.099 0.010
  Physical activity → Brain −0.129 0.107
  Physical activity → Brain −0.132 0.126
  Intellectual enrichment → Brain
   Intellectual activity → Brain −0.113 0.125
   Education → Brain −0.164 0.099
  Intellectual enrichment → Brain
   Intellectual activity → Brain −0.112 0.124
   Education → Brain −0.168 0.099
Associations between brain and cognitive measures
  Brain → Memory 0.050 0.118
  Brain → Memory 0.064 0.094
  Brain → Executive function −0.034 0.101
  Brain → Executive function −0.041 0.100
  Brain → Language −0.314 0.094
  Brain → Language −0.318 0.094
Associations between lifestyle and cognitive measures
  Diet → Memory 0.033 0.113
  Diet → Memory 0.023 0.092
  Diet → Executive function 0.023 0.099
  Diet → Executive function 0.042 0.099
  Diet → Language 0.068 0.107
  Diet → Language 0.063 0.107
  Physical activity → Memory 0.070 0.113
  Physical activity → Memory 0.052 0.094
  Physical activity → Executive function 0.002 0.099
  Physical activity → Executive function 0.007 0.098
  Physical activity → Language 0.002 0.102
  Physical activity → Language −0.009 0.102
  Intellectual enrichment → Memory 0.278 0.114 0.014
  Intellectual activity → Memory 
  Education → Memory 0.213 0.102 0.038
Intellectual enrichment → Executive 
function
  Intellectual activity → Executive function 0.385 0.101 <0.001
  Education → Executive function 0.329 0.084 <0.001
Intellectual enrichment → Language
  Intellectual activity → Language 0.251 0.135
  Education → Language 0.325 0.084 <0.001
Intellectual enrichment → Memory 0.184 0.094 0.050
  Intellectual enrichment → Executive 
function
0.327 0.084 0.001
  Intellectual enrichment → Language 0.326 0.084 0.001
The table consists of standardised betas (βs), their SEs, and P values of 
the estimates from the full model with age entered as a covariate. The 
βs can be interpreted as partial correlations. Only significant P values 
(two tailed) are reported. Paths in italics are adjusted for sex and APOE 
status as covariates. 
Table 4 Results of structural equation modelling for model 
3: vascular risk, brain and cognition
βs SE P value
Associations between vascular risk and brain MRI
biomarkers
  Overweight → Brain −0.067 0.101
  Overweight → Brain −0.116 0.173
  Insulin sensitivity → Brain 0.559 0.081 <0.001
  Insulin sensitivity → Brain 0.029 0.006 <0.001
  Plasma cholesterol/HDL → Brain −0.038 0.101
  Plasma cholesterol/HDL → Brain −0.010 0.037
  Plasma homocysteine → Brain 0.177 0.315
  Plasma homocysteine → Brain 0.175 0.372
  Hypertension → Brain 0.076 0.106
  Hypertension → Brain 0.032 0.042
Associations between brain and cognitive measures
  Brain → Memory 0.032 0.125
  Brain → Memory 0.042 0.123
  Brain → Executive function −0.032 0.101
  Brain → Executive function −0.037 0.101
  Brain → Language −0.325 0.095
  Brain → Language −0.327 0.095
Associations between vascular risk and cognitive measures
  Overweight → Memory −0.195 0.119
  Overweight → Memory −0.191 0.119
  Overweight → Executive function −0.230 0.091 0.012
  Overweight → Executive function −0.229 0.091 0.012
  Overweight → Language −0.006 0.095
  Overweight → Language −0.008 0.095
  Insulin sensitivity → Memory 0.082 0.116
  Insulin sensitivity → Memory 0.041 0.124
  Insulin sensitivity → Executive 
function
−0.072 0.097
  Insulin sensitivity → Executive 
function
−0.064 0.096
  Insulin sensitivity → Language −0.480 0.075 <0.001
  Insulin sensitivity → Language −0.490 0.074 <0.001
  Plasma homocysteine → Memory −0.298 0.164
  Plasma homocysteine → Memory −0.183 0.196
  Plasma homocysteine → Executive 
function
−0.190 0.140
  Plasma homocysteine → Executive 
function
−0.188 0.122
  Plasma homocysteine → Language −0.218 0.338
  Plasma homocysteine → Language −0.358 0.294
  Cholesterol/HDL → Memory −0.051 0.115
  Cholesterol/HDL → Memory −0.042 0.112
  Cholesterol/HDL → Executive 
function
−0.138 0.097
  Cholesterol/HDL → Executive 
function
−0.030 0.101
  Cholesterol/HDL → Language −0.057 0.096
Continued
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Discussion
The major conclusions of this study were the following: 
(1) among lifestyle and vascular risk factors, diet and 
insulin sensitivity explained variability in brain cortical 
thickness in cognitively healthy, middle-aged adults; (2) 
MRI measures of limbic structures in turn explained vari-
ability in memory performance; (3) intellectual enrich-
ment and increased BMI explained variability in cognitive 
performance through different pathways.
Our results indicate that diet and insulin sensitivity may 
be among the earliest modifiable risk factors to influence 
the expression of AD biomarkers, suggesting these modi-
fiable risk factors may alter risk of AD pathophysiology 
during middle age. These associations were independent 
of age, sex and APOE genotype.
Findings of associations between lower MeDi adher-
ence and increased brain atrophy are consistent with the 
literature in the elderly.19 24 35 36 Likewise, we and others 
have described strong associations between insulin resis-
tance and limbic cortex atrophy in both adolescents and 
non-demented elderly.20 28 37 Our data extend prior obser-
vations to a population of middle-aged healthy adults 
and offers a comprehensive view of how the interplay of 
lifestyle and vascular factors influences possible AD risk. 
Indeed, besides being linked with lower risk of dementia, 
the MeDi was shown to support healthier insulin regu-
lation and cardiovascular health.38 Given the known 
increased AD risk associated with prediabetes and type 2 
diabetes,39 our findings fit with increased cardiovascular 
risk being a driver of increased brain ageing and AD.
The statistical approach we employed allowed us to 
simultaneously examine several lifestyle and vascular 
risk factors and discern their independent as well as 
intercorrelated effects on brain atrophy and cognition. 
Other studies that used SEM reported minimal or null 
associations between physical and intellectual activities 
and AD biomarkers in non-demented elderly, although 
biomarkers independently predicted cognitive func-
tion.12 40 These studies, however, did not take into account 
diet or vascular risk. Our study in a younger cohort 
(mean age 50 vs 78–82 years12 40) indicates that phys-
ical and intellectual activity do not impact brain ageing 
as much as diet does during the normal stages of cogni-
tion. When vascular risk factors were accounted for in 
the model, insulin sensitivity influences cortical thickness 
and its effects on limbic regions had significant effects 
on memory performance. These effects were present 
accounting for the impact of exercise, intellectual activity 
and additional vascular risk factors.
In our cohort, insulin resistance was strongly associated 
with increased BMI (ie, overweight). Although BMI was 
not directly associated with MRI measures, it negatively 
impacted memory and executive function through other 
pathways. It has long been known that midlife obesity 
affects cognitive performance,41 possibly by promoting 
cardiovascular disease (CVD) and Aβ deposition.42
Additionally, intellectual enrichment was associated 
with better cognitive performance, suggesting a protec-
tive effect on AD risk. It is possible that continued intel-
lectual stimulation may lower the risk or delay the onset 
of AD by enhancing cognitive reserve, as suggested by 
studies in the elderly.9 11–14 40
Several issues require further consideration. First, our 
results are cross-sectional and do not allow for determina-
tion of causality or temporal relationships between life-
style, vascular risk, brain biomarkers and cognitive status. 
Studies with larger samples and longitudinal follow-ups 
are needed to examine lifestyle and vascular risk factors 
as possible AD risk modifiers. From a statistical perspec-
tive, even though our model fits were adequate and the 
observed relationships were supported by the data, the 
associations were not so strong to yield an ideal model fit. 
To better evaluate the impact of modifiable risk factors on 
brain ageing, we performed additional linear regression 
analyses to estimate R-squared values for the predictors 
identified in the reduced SEM models. R-squared is the 
‘per cent of variance explained’ by the model (eg, the 
fraction by which the variance of the errors is less than 
the variance of the dependent variable). As with SEM 
analysis, diet and insulin sensitivity were both signifi-
cant predictors of brain structure, yielding a combined 
R-squared=0.28 (age adjusted), P<0.001. In other words, 
the combination of diet and insulin sensitivity explained 
28% of the variance in brain MRI measures. Addition-
ally, intellectual enrichment and BMI explained 11% 
and 8% of the variance in cognitive measures, respec-
tively (P≤0.022). As such, these modifiable risk factors 
were fairly good predictors after adjusting for all other 
variables in the model. The associations were none-
theless modest, which is not unexpected in a relatively 
young, healthy population. That said, caution should be 
exerted in interpreting these data. For instance, some of 
the null associations may depend on sample size limita-
tions. However, null effects observed in our cohort are 
consistent with negative findings from large-scale studies 
in the elderly.12 40 Therefore, we offer that the strongest 
arguments of the study are the significant findings which 
manifest themselves despite these limitations. Overall, 
βs SE P value
  Cholesterol/HDL → Language −0.052 0.095
  Hypertension → Memory −0.084 0.129
  Hypertension → Memory −0.084 0.130
  Hypertension → Executive function −0.092 0.099
  Hypertension → Executive function −0.073 0.098
  Hypertension → Language −0.176 0.095
  Hypertension → Language −0.179 0.094
The table consists of standardised betas (βs), their SEs, and P values 
of the estimates from the full model with age entered as a covariate. 
The βs can be interpreted as partial correlations. Only significant P 
values (two tailed) are reported. Paths in italics are adjusted for sex 
and APOE status as covariates. 
HDL, high-density lipoprotein.
Table 4 Continued 
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our data suggest that lifestyle and vascular risk have an 
impact on brain ageing during midlife, thus supporting 
further investigation of modifiable risk factors for healthy 
brain ageing and AD risk reduction.
As with other studies in asymptomatic at-risk indi-
viduals,18 43 44 imaging biomarkers were only modestly 
associated with cognitive measures, most likely because 
our patients were all cognitively normal and younger 
than 60. Previous studies have demonstrated that 
associations between brain biomarkers and cognition 
are evident in clinical populations, such as those with 
clear brain pathology but not among normal popula-
tions.45 Nonetheless, associations between limbic MRI 
measures and memory were significant, indicating that 
modifiable risk factors may impact cognitive health 
before old age.
We cannot exclude that our screening criteria may 
have biased effect estimates.46 For instance, participa-
tion was limited to healthy, middle-aged individuals 
without severe cardiac and CVD. Our goal was to iden-
tify possible vascular, metabolic and lifestyle correlates 
of brain health, prior to severe disease and at a young 
enough age for potential interventions to be impactful. 
However, this makes our population restricted in the vari-
ability of cardiometabolic disease. As such, our results are 
only relevant to middle-aged, cognitively normal, healthy 
men and women without active CVD, stroke or diabetes. 
Nonetheless, our results are in keeping with prospective, 
community-based studies of non-diabetic populations 
showing that insulin resistance and increased blood 
sugar levels, even at levels considered normal in standard 
glucose tests, increase AD risk.47
Another limitation of the study pertains to the char-
acterisation of lifestyle habits. We used self-report ques-
tionnaires of diet and lifestyle, which are vulnerable to 
error and may not have captured relevant dimensions of 
lifestyle activities that influence cognitive functioning. 
Additionally, given the cross-sectional nature of our study 
and synchronous timing of lifestyle and MRI assessments, 
we cannot exclude the possibility that dietary adherence 
or physical activity levels were short-term choices in this 
cohort, which are less likely to impact brain biomarkers 
than long-term choices. However, 90% of participants 
reported living the lifestyle assessed in the surveys for 5 
years or more.
Although MRI measures of neurodegeneration are 
sensitive to early AD changes, they are believed to 
emerge after changes in neuronal activity and down-
stream to Aβ accumulation.16 As such, MRI measures 
are not specific to AD and offer limited information 
on whether the observed associations were due to AD 
or to other causes of cortical thinning. Amyloid and 
tau biomarkers specific to AD are warranted to inves-
tigate the potential of lifestyle and vascular risk inter-
vention for AD prevention. However, Aβ deposition is 
an age-dependent phenomenon, with 0% of cognitively 
normal individuals aged 45–49 years and less than 6% 
of those in the fifth decade of life testing positive for 
Aβ.48 Considering that all our participants were cogni-
tively normal and between 30 and 60 years of age, very 
few (if any) would have had substantial amyloid burden, 
making this cohort an ideal population for testing of 
primary prevention strategies.
We caution that present results were found in small 
numbers of carefully screened patients who were evalu-
ated under controlled clinical conditions. Longitudinal 
studies with larger samples are needed to replicate and 
assess the generalisability of these preliminary find-
ings in community-based populations with higher vari-
ability in socioeconomic and medical status, as well as to 
incorporate other AD biomarkers. Should preventative 
studies prove successful, work will be needed to estimate 
the effects of increased longevity on dementia burden 
in such an increasingly older, although healthier, 
population.
In conclusion, our results suggest that a well-rounded 
lifestyle that incorporates a healthy diet (such as the 
MeDi), reduces vascular risk factors (especially insulin 
resistance and overweight) and promotes intellectual 
activity might be neuroprotective during ageing. More 
studies are needed to evaluate midlife lifestyle and 
vascular risk factor modification for AD prevention.
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